repaglinide

Generic: repaglinide

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name repaglinide
Generic Name repaglinide
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

repaglinide 2 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 57237-159
Product ID 57237-159_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203820
Listing Expiration 2026-12-31
Marketing Start 2014-01-22

Pharmacologic Class

Established (EPC)
glinide [epc]
Mechanism of Action
potassium channel antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 57237159
Hyphenated Format 57237-159

Supplemental Identifiers

RxCUI
200256 200257 200258
UPC
0357237157015 0357237158012 0357237159019
UNII
668Z8C33LU
NUI
N0000175428 N0000175448

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name repaglinide (source: ndc)
Generic Name repaglinide (source: ndc)
Application Number ANDA203820 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (57237-159-01)
  • 500 TABLET in 1 BOTTLE (57237-159-05)
source: ndc

Packages (2)

57237-159-01 100 TABLET in 1 BOTTLE (57237-159-01) 57237-159-05 500 TABLET in 1 BOTTLE (57237-159-05)

Ingredients (1)

repaglinide (2 mg/1)

Linked Drug Pages (1)

Repaglinide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4", "openfda": {"nui": ["N0000175428", "N0000175448"], "upc": ["0357237157015", "0357237158012", "0357237159019"], "unii": ["668Z8C33LU"], "rxcui": ["200256", "200257", "200258"], "spl_set_id": ["d7673e22-0dbb-4395-ad60-943d249203a1"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (57237-159-01)", "package_ndc": "57237-159-01", "marketing_start_date": "20140122"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (57237-159-05)", "package_ndc": "57237-159-05", "marketing_start_date": "20140122"}], "brand_name": "Repaglinide", "product_id": "57237-159_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "57237-159", "generic_name": "Repaglinide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "2 mg/1"}], "application_number": "ANDA203820", "marketing_category": "ANDA", "marketing_start_date": "20140122", "listing_expiration_date": "20261231"}